Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,164.00
Bid: 1,162.00
Ask: 1,166.00
Change: 10.00 (0.87%)
Spread: 4.00 (0.344%)
Open: 1,170.00
High: 1,172.00
Low: 1,146.00
Prev. Close: 1,154.00
SVS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Savills IM & Samsung Life Investment Alliance

27 May 2021 08:04

RNS Number : 0178A
Savills PLC
27 May 2021
 

27 05 21

 

Savills announces Strategic Investment Alliance between Savills IM and Samsung Life

Savills plc, the global real estate services provider, announces that its subsidiary Savills Investment Management has entered into an agreement to form a Strategic Investment Alliance with Samsung Life, the leading Life Insurer in Korea, and its real estate asset management subsidiary Samsung SRA. As part of this agreement Samsung Life will acquire a minority interest in Savills IM Holdings Limited ("Savills IM") and commit capital of US$1bn to Savills IM's investment strategies over the initial four years of the relationship (the "Initial Term") (collectively the "Transaction"). The Transaction, which is conditional on various regulatory approvals and other customary closing conditions, is expected to complete in Q4, 2021.

On completion of the Transaction, Samsung Life will acquire an initial minority stake of 25% in Savills IM for £63.75m in cash, subject to completion adjustments. Under the agreement, Samsung Life has options to increase its interest in Savills IM by up to a further 10% over the Initial Term, depending upon the quantum and timing of the provision of capital to Savills IM's investment products, the maximum being achievable if at least US$2bn of capital is committed.

Savills IM and Samsung Life will enter a Shareholders' Agreement which covers the working relationship between the parties. Amongst other things it provides customary minority protections to Samsung Life whilst maintaining the complete operational and investment autonomy with which Savills IM currently operates. The investment strategies for Samsung Life include both investment in existing recently launched products and seed capital for new funds. The products target Asia Pacific and Europe and include debt and equity strategies. 

As part of the alliance, Savills IM will form a close working relationship with Samsung SRA which will seek to bring additional Korean client capital to Savills IM's products alongside the capital commitment of Samsung Life's and Savills IM's other investment clients.

For the year to 31 December 2020, Savills IM reported profit before tax of £14.9m. On a proforma basis, including the full year effect of the recently announced acquisition of the remaining A member interests in DRC Capital LLP, 2020 reported profit before tax would have been £19.3 million. The gross assets that are the subject of this transaction amounted to £101.4 million as at 31 December 2020 (excluding the consolidation of DRC Capital LLP). The proceeds from the sale will be used by Savills plc for general corporate purposes.

Commenting on the Transaction, Alex Jeffrey, CEO of Savills Investment Management said:

"This transformational alliance will be unique in the industry, combining Savills IM's existing strengths as an investment manager with extensive local transaction and asset management capability in real estate debt and equity markets, with the strong capital support of Samsung Life. It will significantly enhance and accelerate our ability to provide attractive investment products for all our investment clients."

Mark Ridley, CEO of Savills plc commented:

"Samsung Life is a long-standing client of Savills both in Korea and internationally and this transaction will allow the strengths of both Savills Group and Samsung Life to drive further growth in the Savills Investment Management platform."

Youngmuk Jeon, CEO of Samsung Life, commented:

"Samsung Life is excited to invest in Savills IM, one of Europe's leading real estate asset management platforms. We are confident that Savills IM is well positioned to help us expand our real estate investment network globally and that this strategic alliance, underpinned by our capital provision, will support and accelerate Savills IM's growth over the long term."

Bumchul Lim, CEO of Samsung SRA Asset Management, added:

"Samsung SRA is delighted to establish an alliance with Savills IM. It will strengthen our ability to provide attractive real estate investment opportunities at a time of heightened investor demand. With its 30-year track record, extensive network of 16 offices across 13 countries in Europe and Asia and broad product range, Savills IM is well positioned to address this market opportunity." 

 

For further information, contact:

 Savills

020 7409 8934

Mark Ridley, Group Chief Executive Officer

Simon Shaw, Group Chief Financial Officer

 

 

 Savills Investment Management

Alex Jeffrey, Chief Executive Officer , Savills Investment Management

 

+ 65 8907 7538

Tulchan Communications

020 7353 4200

Elizabeth Snow

Mark Burgess

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISGRGDUBGDDGBR
Date   Source Headline
2nd May 20248:28 amRNSTotal Voting Rights
26th Apr 20242:13 pmRNSDirector/PDMR Shareholding
26th Apr 202411:21 amRNSDirector Declaration
15th Apr 20243:42 pmRNSDirector/PDMR Shareholding
12th Apr 20245:12 pmRNSDirector/PDMR Shareholding
8th Apr 20243:47 pmRNSAnnual Report and AGM Notice
21st Mar 20248:17 amRNSDirector/PDMR Shareholding
19th Mar 20245:11 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSNon-Executive Director Appointment
14th Mar 20247:00 amRNSFinal Results
13th Mar 20241:37 pmRNSDirector/PDMR Shareholding
15th Feb 202410:00 amRNSBlock listing Interim Review
13th Feb 20246:07 pmRNSDirector/PDMR Shareholding
1st Feb 202411:00 amRNSTotal Voting Rights
22nd Jan 20249:11 amRNSBlock listing Interim Review
11th Jan 20244:02 pmRNSDirector/PDMR Shareholding
11th Jan 20247:00 amRNSYear End Trading Update
2nd Jan 202412:33 pmRNSTotal Voting Rights
15th Dec 202310:00 amRNSAdditional Listing
14th Dec 202312:56 pmRNSDirector/PDMR Shareholding
13th Dec 202311:42 amRNSNon-Executive Director Appointment
13th Nov 20232:02 pmRNSSAVILLS APPOINTS NEW CEO OF SAVILLS NORTH AMERICA
13th Nov 202312:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20233:16 pmRNSForm 8.3 - OntheMarket PLC
1st Nov 202310:00 amRNSTotal Voting Rights
27th Oct 202310:00 amRNSAdditional Listing
12th Oct 20233:41 pmRNSDirector/PDMR Shareholding
2nd Oct 20238:50 amRNSTotal Voting Rights
22nd Sep 202311:00 amRNSAdditional Listing
12th Sep 20235:10 pmRNSTotal Voting Rights
1st Sep 202311:00 amRNSTotal Voting Rights
18th Aug 20232:00 pmRNSAdditional Listing
15th Aug 20234:06 pmRNSBlock listing Interim Review
14th Aug 20232:05 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSChair Succession
10th Aug 20237:00 amRNSHalf-year Report
21st Jul 202310:00 amRNSBlock listing Interim Review
11th Jul 202312:50 pmRNSDirector/PDMR Shareholding
4th Jul 20239:20 amRNSTotal Voting Rights
13th Jun 20235:31 pmRNSDirector/PDMR Shareholding
1st Jun 202310:00 amRNSTotal Voting Rights
17th May 20234:05 pmRNSResult of AGM
17th May 20237:00 amRNSAGM Statement
11th May 20236:12 pmRNSDirector/PDMR Shareholding
2nd May 20237:00 amRNSTotal Voting Rights
28th Apr 20234:07 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSDirector/PDMR Shareholding
24th Apr 20235:15 pmRNSDirector/PDMR Shareholding
12th Apr 20232:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:15 pmRNSAnnual Report and AGM Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.